Marie Egan, M.D.
Chief Clinical Advisor and Co-founder
Dr. Marie Egan is a Professor of Pediatrics (Respiratory) and Cellular and Molecular Physiology at Yale University. She also serves as a Director of the Cystic Fibrosis Center, Vice Chair of Research for the Department of Pediatrics, and Interim Chief of Pediatric Pulmonary Allergy Immunology and Sleep Medicine at Yale University. Her primary research interest […]
Akiko Iwasaki, Ph.D.
Chief Preclinical Advisor and Co-founder
Dr. Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular, and Developmental Biology at Yale University, and an Investigator of the Howard Hughes Medical Institute. Her research focuses on the mechanisms of immune defense against viruses at mucosal surfaces, and the development of mucosal vaccine strategies. She is the co-Lead Investigator of the […]
Alexandra Piotrowski-Daspit, Ph.D.
Co-founder
Dr. Alexandra (Alex) Piotrowski-Daspit is an Assistant Professor of Biomedical Engineering and Internal Medicine – Pulmonary & Critical Care Medicine Division at the University of Michigan. Alex received her bachelor’s degree in Chemical-Biological Engineering and Biology from the Massachusetts Institute of Technology (MIT) and her Ph.D. in Chemical & Biological Engineering from Princeton University. She trained […]
W. Mark Saltzman, Ph.D.
Chief Scientific Advisor, Co-founder, and Member of Board
Dr. W. Mark Saltzman is the Goizueta Foundation Professor of Chemical and Biomedical Engineering at Yale University. His research interests include materials for controlled drug delivery, drug delivery to the brain, and tissue engineering. He has taught at Johns Hopkins University and Cornell University and, after joining the Yale faculty in 2002, was named the […]
Matt Simon, Ph.D.
Chief RNA Advisor and Co-founder
Dr. Matt Simon is an Associate Professor and Director of Graduate Admissions, Biochemistry, Quantitative Biology, and Biophysics and Structural Biology (BQBS) at Yale University. His group’s research focuses on developing new chemical and biochemical means of investigating regulated gene expression at the level of chromatin and RNA biology. Matt received a B.S. in Biochemistry from […]
Bruce Turner, M.D., Ph.D.
Chief Executive Officer, Co-founder, and Chairman
Dr. Bruce Turner is a medically trained oncologist with deep experience spanning genetic research, drug development and healthcare portfolio management. Prior to founding Xanadu, Dr. Turner spent five years at Hoffman-La Roche in various position of increasing responsibility in R&D and was vice president at Ionis Pharmaceuticals, Inc. working in cardiovascular/ metabolic drug development. Dr. […]
Todd Wider, M.D.
Chief Medical Officer, Co-Founder, and Member of Board
Dr. Todd Wider is the Chairman of the Board of Directors and Chief Medical Officer at Emendo Bio and serves as a consultant to numerous entities in the biotechnology space. Todd graduated from Princeton University and received a M.D. from Columbia College of Physicians and Surgeons. He completed his surgery and plastic and reconstructive surgery […]
Taylor Feehley, Ph.D.
Chief Operating Officer
Dr. Taylor Feehley is a published immunology researcher with experience in life science corporate development and strategy. Most recently, she served in various senior corporate strategy and development roles at Omega Therapeutics and Vedanta Biosciences. Prior to joining Vedanta, she was a Senior Research Analyst at Chardan with a specialty in genetic medicines, infectious disease, […]